Streamline Surgical System vs iStent for Open-Angle Glaucoma (VENICE Trial)

Recruiting in Palo Alto (17 mi)

+20 other locations

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: New World Medical, Inc.

No Placebo Group

Trial Summary

What is the purpose of this trial?A study of the Streamline Surgical System versus competitor

Eligibility Criteria

This trial is for people with mild to moderate Primary Open-Angle Glaucoma. It's not open to those with other glaucoma types like normal tension, pseudoexfoliative, narrow angle, traumatic, congenital, malignant, uveitic or neovascular glaucoma or just ocular hypertension.

Inclusion Criteria

I have been diagnosed with mild to moderate open-angle glaucoma.

Exclusion Criteria

I have high eye pressure.

I have a specific type of glaucoma, not the most common one.

Participant Groups

The study compares two treatments for Open-Angle Glaucoma: the Streamline Surgical System and iStent Inject W. Patients will receive one of these interventions to see which is more effective.

2Treatment groups

Experimental Treatment

Active Control

Group I: Streamline Surgical SystemExperimental Treatment1 Intervention

Streamline Surgical System procedure administered

Group II: iStent Inject WActive Control1 Intervention

iStent Inject W implanted